集中度低或下降

港股IPO招股书披露先例 · 31 家公司,31 项

此类事项指招股书披露前五大供应商或最大供应商的采购占比较低或呈下降趋势,以说明公司并无重大依赖任何供应商。相关内容常见于概要、风险因素、业务及财务资料章节,通常列示各期向前五大及最大供应商的采购金额与占比、供应商类别及独立第三方身份,并解释公司通过维持多元供应商基础、严格的遴选评估制度、集中采购或长期协议等方式降低依赖,或已物色条款相若的替代供应商。

2026-09-18Application Proof
浙江京新药业股份有限公司Zhejiang Jingxin Pharmaceutical Co., Ltd.

前五大供应商采购占比约16%至20%

Purchases from our five largest suppliers in each period during the Track Record Period were RMB318.0 million, RMB372.2 million, RMB349.4 million and RMB193.0 million in 2023, 2024, 2025 and the six months ended June 30, 2026, respectively, representing approximately 16.3%, 17.0%, 18.4% and 19.9% of our total purchases for the respective periods.

Business · 第 139 页

We select our suppliers by considering cost and their capability, quality, reputation, delivery and regulatory compliance.

Business · 第 139 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-13Application Proof
深圳市海柔创新智能科技集团股份有限公司Hai Robotics Innovation Group Co., Ltd.

前五大供应商采购占比14.1%至19.0%

In 2023, 2024 and 2025 and for the six months ended June 30, 2026, purchases from our five largest suppliers in each period during the Track Record Period were RMB158.2 million, RMB255.9 million, RMB298.3 million and RMB122.3 million, respectively, accounting for 16.5%, 19.0%, 18.7% and 14.1% of our total purchase amounts for the same periods, respectively.

Business · 第 157 页

Our Directors confirmed that, during the Track Record Period and up to the Latest Practicable Date, we have not experienced any significant material fluctuation in prices set by our suppliers, material breach of contract on the part of our suppliers or material delay in delivery of our orders from our suppliers.

Business · 第 160 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-28Prospectus
深圳麦科田生物医疗技术股份有限公司Medcaptain Medical Technology Co., Ltd.02041.HK

前五大供应商采购占比下降,无依赖单一供应商

Purchases from our five largest suppliers accounted for 19.1%, 12.1%, 9.0% and 6.7%, respectively, of our total purchases in 2023, 2024 and 2025 and the three months ended March 31, 2026. Purchases from our largest supplier accounted for 8.9%, 3.6%, 2.2% and 2.3%, respectively, of our total purchases in 2023, 2024 and 2025 and the three months ended March 31, 2026.

Business · 第 191 页

We do not rely on any of our current suppliers as there are viable substitutes available on the market to meet our needs at a comparable price and quality.

Business · 第 192 页

We believe we have alternative sources for the supply of principal raw materials with comparable quality and prices.

Business · 第 192 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-20Application Proof
博纳西亚(杭州)医药科技股份有限公司PANACRO (Hangzhou) Pharmaceutical Consulting Co., Ltd.

前五大供应商采购占比及集中度管理

During the Track Record Period, the total amount purchased from our top five suppliers in each year or period during the Track Record Period amounted to RMB38.3 million, RMB29.1 million, RMB20.2 million and RMB15.1 million in 2023, 2024 and 2025 and the six months ended June 30, 2026, respectively, representing 28.6%, 25.4%, 18.3% and 20.5% of our total purchase amount for the respective periods.

Business · 第 157 页

We seek to manage supplier concentration and the impact of cost fluctuations through various measures, such as maintaining a diversified supplier pool, obtaining competitive quotations where appropriate, and negotiating commercial terms.

Business · 第 156 页

During the Track Record Period, all of our top five suppliers in each year or period during the Track Record Period were Independent Third Parties.

Business · 第 156 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-07-29Application Proof
深圳粤十控股股份有限公司Shenzhen Yueshi Holding Co., Ltd.

前五大供应商采购占比2023年达53.0%

In 2023, 2024 and 2025 and for the four months ended April 30, 2026, purchases from our five largest suppliers in each year/period during the Track Record Period amounted to RMB652.4 million, RMB779.6 million, RMB1,046.7 million and RMB608.0 million, respectively, accounting for 53.0%, 26.8%, 18.1% and 22.3% of our total purchases in the same periods, respectively.

Summary · 第 4 页

In 2023, 2024 and 2025 and for the four months ended April 30, 2026, purchases from our five largest suppliers in each year/period during the Track Record Period amounted to RMB652.4 million, RMB779.6 million, RMB1,046.7 million and RMB608.0 million, respectively, accounted for 53.0%, 26.8%, 18.1% and 22.3% of our total purchases in the same periods, respectively.

Business · 第 160 页

For critical product categories, we seek to maintain multiple sourcing options or contingency arrangements to mitigate supply concentration risk.

Business · 第 158 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-15Prospectus
上海仙工智能科技股份有限公司Shanghai Seer Intelligent Technology Co., Ltd.06106.HK

前五大供应商采购占比40.1%、38.7%及32.6%

In 2023, 2024 and 2025, our aggregate purchase from the five largest suppliers in each year during the Track Record Period was RMB50.7 million, RMB71.0 million and RMB75.8 million, respectively, accounting for 40.1%, 38.7% and 32.6% of our total cost of sales, respectively.

Business · 第 163 页

Based on the foregoing, although our top five suppliers for each year during the Track Record Period accounted for a considerable portion of our total cost of sales for the same years, our Directors are of the view that we do not rely on any single supplier.

Business · 第 165 页

Our Directors confirm that we had not experienced any significant material fluctuation in prices set by our suppliers, material breach of contract on the part of our suppliers or delay in delivery of our orders from our suppliers during the Track Record Period.

Business · 第 165 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-12Application Proof
宁波三星医疗电气股份有限公司NINGBO SANXING MEDICAL ELECTRIC CO., LTD.

前五大供应商采购占比11.3%至14.0%

For the years ended December 31, 2023, 2024 and 2025, our purchases from our five largest suppliers in each period in aggregate amounted to RMB1,128.1 million, RMB1,058.4 million and RMB1,163.4 million, respectively, representing 14.0%, 11.3% and 13.2% of our total purchases in the corresponding periods.

Business · 第 160 页

For the same period, our purchases from our largest supplier amounted to RMB468.5 million, RMB296.0 million and RMB314.4 million, respectively, representing 5.8%, 3.2% and 3.6% of our total purchases in the corresponding periods.

Business · 第 160 页

To minimize the risk of reliance on any single supplier and maintain sourcing stability and bargaining power, we generally retain multiple suppliers for our principal raw materials and equipment.

Business · 第 150 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-19Application Proof
苏州东山精密制造股份有限公司Suzhou Dongshan Precision Manufacturing Co., Ltd.

前五大供应商采购占比约两至三成

In 2023, 2024 and 2025, purchases from our five largest suppliers amounted to RMB5,975.4 million, RMB6,214.4 million and RMB5,737.5 million, accounting for 25.8%, 26.1% and 21.9% of our total purchases in the respective years.

Business · 第 156 页

In 2023, 2024 and 2025, purchases from our largest supplier amounted to RMB2,034.5 million, RMB1,674.4 million and RMB1,463.8 million, accounting for 8.8%, 7.0% and 5.6% of our total purchases in the respective years.

Business · 第 156 页

Our suppliers are mainly suppliers of raw materials and equipment. We have established and maintain stable and long-term relationships with these major suppliers.

Business · 第 155 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-15Application Proof
山东安得医疗用品股份有限公司Shandong Ande Healthcare Apparatus Co., Ltd.

前五大供应商采购占比约两成

In 2023, 2024 and 2025, purchases from our five largest suppliers amounted to RMB91.4 million, RMB75.2 million and RMB63.2 million, respectively, representing 21.7%, 18.7% and 17.7% of our total purchases, respectively.

Summary · 第 5 页

In addition, purchases from our largest supplier accounted for 5.1%, 5.0% and 5.3% of our total purchases in 2023, 2024 and 2025, respectively. All of our five largest suppliers were Independent Third Parties during the Track Record Period.

Business · 第 130 页

Additionally, we did not experience any material disputes with our suppliers during the Track Record Period.

Business · 第 130 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-05-13Application Proof
宁波菲仕技术股份有限公司Ningbo Physis Technology Co., Ltd.

前五大供应商采购占比约两成,最大供应商占7.1%

In 2023, 2024 and 2025, purchase from our top five suppliers in each period during the Track Record Period accounted for 20.3%, 21.8% and 22.4% of our total purchases for such period, respectively, and purchase from our largest supplier in each period during the Track Record Period accounted for 5.6%, 7.1% and 7.1% of our total purchases for such period, respectively.

Summary · 第 4 页

In 2023, 2024 and 2025, purchase from our top five suppliers in each period during the Track Record Period accounted for 20.3%, 21.8% and 22.4% of our total purchases for such period, respectively, and purchase from our largest supplier in each period during the Track Record Period accounted for 5.6%, 7.1% and 7.1% of our total purchases for such period, respectively.

Business · 第 143 页

Although we have not encountered any material price fluctuation in key raw materials that may impact our capability to timely deliver products and solutions during the Track Record Period, to mitigate risks related to raw material prices and supply, we have deployed a hybrid procurement model that dynamically balances order-driven requirements with safety stock buffers, managed through a centralized procurement platform overseeing material needs of the entire Group.

Business · 第 143 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-04-30Application Proof
四川新荷花中药饮片股份有限公司Sichuan Neautus Traditional Chinese Medicine Co., Ltd.

前五大供应商采购占比由36.0%降至20.6%

In each year during the Track Record Period, purchases from our five largest suppliers accounted in aggregate for approximately 36.0%, 23.3% and 20.6% of our total purchases in 2023, 2024 and 2025. In each year during the Track Record Period, our single largest supplier accounted for approximately 11.9%, 7.2% and 6.1% of our total purchases in 2023, 2024 and 2025.

Business · 第 171 页

To secure a stable supply of raw materials and reduce our risk of supply disruption, we have strategically selected our raw material suppliers and sourced our raw materials from a diversified mix of suppliers in different geographic regions in the PRC.

Business · 第 171 页

To the best knowledge of our Directors, none of our Directors or their associates or any person who owned 5% or more of our issued share capital as at the Latest Practicable Date had any interest in any of our five largest suppliers during the Track Record Period, and all our suppliers during the Track Record Period were Independent Third Parties.

Business · 第 173 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-04-27Application Proof

前五大供应商采购占比约26.0%

Purchases from the five largest suppliers in each year during the Track Record Period accounted for approximately 23.2%, 21.8% and 26.0% of our total purchases for the respective year.

Summary · 第 7 页

We source different raw materials from multiple suppliers in mitigating the risk of single supplier reliance and ensuring the timely delivery of our products.

Business · 第 144 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-04-24Application Proof

向最大供应商采购占比35.7%至24.3%

Purchase from our top five suppliers accounted for 51.5%, 44.8% and 44.2% of our total purchases in 2023, 2024 and 2025, respectively, and purchase from our largest supplier accounted for 35.7%, 26.6% and 24.3% of our total purchases in the same periods, respectively.

Summary · 第 5 页

under which we purchased operational support services from Supplier A, including order fulfillment, storage, and customer services, among others. In general, we are required to pay a commission to Supplier A, which is typically a certain percentage rate of our sales revenue generated through our online stores on the same E-commerce marketplace.

Business · 第 165 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-04-01Application Proof
石大胜华新材料集团股份有限公司Shida Shinghwa Advanced Material Group Co., Ltd.

前五大供应商采购占比及多源采购策略

In 2023, 2024 and 2025, the aggregate purchases from our five largest suppliers in each period during the Track Record Period amounted to RMB1,703.3 million, RMB1,385.6 million and RMB1,324.2 million, respectively, which accounted for 35.4%, 28.3% and 23.3% of our total purchases for the corresponding periods.

Business · 第 115 页

We adopt a multi-supplier sourcing strategy to mitigate supply disruption risks and maintain long-term strategic partnerships with major suppliers to ensure stability in pricing and supply.

Business · 第 111 页

During the Track Record Period, our principal raw material suppliers were domestic large-scale chemical and energy enterprises, including several state-owned enterprises and listed companies with leading positions in the industry, extensive production experience and stable supply capabilities.

Business · 第 113 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-02-05Prospectus
深圳市沃尔核材股份有限公司Shenzhen Woer Heat-Shrinkable Material Co., Ltd.09981.HK

前五大供应商采购占比为15.8%至22.6%

In each year during the Track Record Period, our purchases from our five largest suppliers in each year/period during the Track Record Period accounted for 21.9%, 22.6%, 18.0% and 15.8% of our total purchases for the respective year/period respectively, while our purchase from the largest supplier in each year/period during the Track Record Period accounted for 8.3%, 7.1%, 6.6% and 4.5% of our total purchases for the respective year/period.

Business · 第 170 页

We believe that our operation is not dependent on any particular supplier. During the Track Record Period, we maintained multiple suppliers to avoid overreliance on any of suppliers and we believe there is no significant difficulty to find suitable substitutes for our suppliers.

Business · 第 174 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-01-27Prospectus
青岛国恩科技股份有限公司QINGDAO GON TECHNOLOGY CO., LTD.02768.HK

前五大供应商采购占比及最大供应商占比下降

Our top five suppliers for FY2022, FY2023, FY2024 and 10MFY2025 together accounted for 42.5%, 35.3%, 35.5% and 23.7%, respectively, of our total purchases during the same year/period.

Summary · 第 4 页

Purchases from our top five suppliers in FY2022, FY2023, FY2024 and 10MFY2025 amounted to RMB5,052.3 million, RMB5,642.3 million, RMB6,145.5 million and RMB3,769.5 million, which accounted for 42.5%, 35.3%, 35.5% and 23.7%, respectively, of our total purchases of the corresponding year/period.

Business · 第 200 页

Purchases from our single largest supplier amounted to RMB1,882.5 million, RMB2,170.5 million, RMB1,868.3 million and RMB1,047.3 million for FY2022, FY2023, FY2024 and 10MFY2025, representing 15.8%, 13.6%, 10.8% and 6.6% of our total purchases respectively during the corresponding year/period.

Business · 第 200 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-12-09Prospectus

五大供应商采购占比最高达39.1%

In 2022, 2023, 2024 and the six months ended June 30, 2025, purchases from our five largest suppliers were HK$198.5 million, HK$236.1 million, HK$302.1 million and HK$155.4 million, respectively, accounting for 39.1%, 32.4%, 19.2% and 29.4% of our total purchases for the same periods, respectively.

Summary · 第 7 页

In order to minimize dependency on any single supplier and enhance platform resilience, we maintain supplier diversification in key areas such as cloud infrastructure, cybersecurity services and blockchain-related technologies.

Business · 第 309 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-11-07Prospectus
中伟新材料股份有限公司CNGR Advanced Material Co., Ltd.02579.HK

前五大供应商采购占比最高达36.6%

In 2022, 2023 and 2024 and the six months ended June 30, 2025, purchases from our five largest suppliers in each year during the Track Record Period amounted to RMB14,662.7 million, RMB13,734.0 million, RMB10,454.1 million and RMB5,116.3 million, respectively, accounting for 36.5%, 36.6%, 24.9% and 25.7% of our total purchases in the respective periods.

Business · 第 207 页

As of June 30, 2025, we achieved a nickel primary smelting capacity of 165,000 metal tons, sufficient to meet all the nickel-based raw material needs for our new energy battery materials and new energy metal products production for the six months ended June 30, 2025.

Business · 第 206 页

Given our continuous efforts to expand our production capacity in the upstream and midstream resources, we expect the continuous increase in the self-supply rate of our key raw materials for new energy materials in the foreseeable future.

Business · 第 206 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-10-28Prospectus
苏州旺山旺水生物医药股份有限公司Vigonvita Life Sciences Co., Ltd.02630.HK

前五大供应商采购占比及依赖情况

In 2023, 2024 and the four months ended April 30, 2025, our purchases from our five largest suppliers in each year/period during the Track Record Period in aggregate accounted for 36.5%, 15.3% and 11.7% of our total purchases in the respective year/period, respectively, and purchases from our largest supplier alone in each year/period during the Track Record Period accounted for 16.5%, 7.8% and 4.7% of our total purchases in each respective year/period, respectively.

Business · 第 389 页

In addition, we believe that we have adequate alternative sources for such suppliers, and we have developed alternative sourcing strategies to decrease our reliance on existing suppliers.

Business · 第 391 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2025-10-23Prospectus
明略科技Mininglamp Technology02718.HK

前五大供应商采购占比最高约20.5%

Purchases from our five largest suppliers in each period during the Track Record Period amounted to RMB134.0 million, RMB92.6 million, RMB73.8 million, RMB42.0 million and RMB34.1 million, respectively, representing approximately 20.5%, 15.6%, 13.9%, 16.5% and 13.3% of our total purchases in the same periods, respectively.

Summary · 第 11 页

Purchases from our largest supplier accounted for 10.1%, 4.7% and 5.5% of our total purchases in 2022, 2023 and 2024, respectively.

Business · 第 319 页

This approach allows us to focus on our core business activities while leveraging the expertise and efficiency of specialized service providers.

Business · 第 319 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us